Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses

Eur J Hum Genet. 2022 Aug;30(8):922-929. doi: 10.1038/s41431-022-01070-5. Epub 2022 Mar 23.

Abstract

The human leucocyte antigen (HLA) loci have been widely characterized to be associated with viral infectious diseases using either HLA allele frequency-based association or in silico predicted studies. However, there is less experimental evidence to link the HLA alleles with COVID-19 and other respiratory infectious diseases, particularly in the lung cells. To examine the role of HLA alleles in response to coronavirus and other respiratory viral infections in disease-relevant cells, we designed a two-stage study by integrating publicly accessible RNA-seq data sets, and performed allelic expression (AE) analysis on heterozygous HLA genotypes. We discovered an increased AE pattern accompanied with overexpression of HLA-B gene in SARS-CoV-2-infected human lung epithelial cells. Analysis of independent data sets verified the respiratory virus-induced AE of HLA-B gene in lung cells and tissues. The results were further experimentally validated in cultured lung cells infected with SARS-CoV-2. We further uncovered that the antiviral cytokine IFNβ contribute to AE of the HLA-B gene in lung cells. Our analyses provide a new insight into allelic influence on the HLA expression in association with SARS-CoV-2 and other common viral infectious diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allelic Imbalance
  • COVID-19* / genetics
  • HLA Antigens / genetics
  • HLA-B Antigens / genetics
  • Histocompatibility Antigens Class I / genetics
  • Humans
  • Lung
  • SARS-CoV-2*

Substances

  • HLA Antigens
  • HLA-B Antigens
  • Histocompatibility Antigens Class I